Case Report

A Therapeutic Efficacy of Ursodeoxycholic Acid on Cholestasis after The Nutrition Therapy for Starvation Hepatitis

1. Abstract A 42-year-old woman with a history of anorexia nervosa visited to our hospital along with transaminitis of asparate aminotransferase (AST) and alanine aminotransferase (ALT) of 7700 U/mL and 5700 U/mL, respectively, which indicated starvation hepatitis. After refeeding of nutrition, AST/ALT decreased, transient elevated, decreased again, and maintained to 100-600 U/mL, and a liver …

A Therapeutic Efficacy of Ursodeoxycholic Acid on Cholestasis after The Nutrition Therapy for Starvation Hepatitis Read More »

Microbial Onco-Therapeutics

1. Abstract The reasonable development of anticancerous agents that specifically target malignant growth cells without influencing the sound cells or tissues, has prompted another novel interest in microbial-determined bioactive entities.

Synchronous Gastric Adenocarcinoma and Pancreatic Ductal Adenocarcinoma: A Case Report

1. Abstract Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer, often diagnosed at advanced stages with a very poor prognosis. While the synchronous occurrence of pancreatic and gastric cancer is rare, we present a case of an elderly male who underwent investigation for a 3-kilogram weight loss in a month and was …

Synchronous Gastric Adenocarcinoma and Pancreatic Ductal Adenocarcinoma: A Case Report Read More »

Case Reported for Iatrogenic Cystectomy During Cesarean Delivery

1. Abstract Bladder injury is well known complication during Cesarean Delivery (DC). We describe a case of 28 year old woman, who presented in labor. An emergency DC and hysterectomy were done to control bleeding. It was complicated by and inadvertent cystotomy. Urine diverted immediately by. After five months an Augmentation Ilio- Cytoplasty, bilateral ureteric …

Case Reported for Iatrogenic Cystectomy During Cesarean Delivery Read More »

Smarcb1/Ini-1-Deficient Pancreatic Carcinoma with Rhabdoid Features: A Case Report and Literature Review

1. Abstract 1.1. Background: SMARCB1/INI-1-deficient pancreatic carcinoma is a rarely reported entity. So far, only 10 cases have been published in the literature, and most of the reported cases have poor prognosis and mortality rate within six months is extremely high. The clinical presentation, histopathological features, and biologically behaviors are essentially unclear.